baber/WOPTO huggingface dataset:
Patent AU-2003279606-B2 (AU)
Title: Process for the manufacture of a ballistic-resistant moulded article
Inventor: BEUGELS JEAN HUBERT MARIE
IPC: F41H5/04
Filed: 2003-10-31
Granted: 2008-05-29
Abstract: The invention relates to a process for the manufacture of a ballistic-resistant moulded article in which a stack of monolayers is formed, each monolayer containing unidirectionally oriented reinforcing fibres and at most 30 mass% of a plastic matrix material and with the fibre direction in each monolayer being rotated with respect to the fibre direction in an adjacent monolayer, the stack then being compressed at a pressure of more than 25 MPa and a temperature between 125 and 150°C, and the plastic matrix material having a 100% modulus of at least 3 MPa..
Patent AU-2004203839-B2 (AU)
Title: Power tool and debris extraction system therefor
Inventor: PARK KEITH
IPC: B24B23/00
Filed: 2004-08-10
Granted: 2009-06-18
Abstract: The invention relates to the provision of a power tool, such as a sander, which has a working portion which, when moved with respect to a workpiece creates debris. The invention provides a debris collection bag mounted in a housing on the power tool body which allows for the collection of debris from the vicinity of the working portion. The debris collection bag is selectively removable for discarding the debris and/or washing.
Patent AU-2004295264-B2 (AU)
Title: Biodegradable Branched Polylactide Derivatives Capable of Forming Polymeric Micelles, and the Preparation Method and Use
Inventor: KIM BONG-OH
IPC: C08F297/00
Filed: 2004-12-03
Granted: 2009-10-29
Abstract: The present invention relates to a biodegradable branched polylactic acid derivative of formula 1, and preparation method and use thereof: <formula 1> 1-(R—X)n wherein each of X, R, I and n is defined as in the detailed description.
Patent AU-2005221394-B2 (AU)
Title: Safety seat
Inventor: CARINE DAVID SHAUN
IPC: B60N2/48
Filed: 2005-03-11
Granted: 2011-06-02
Abstract: A deformable, polypropylene-moulding lining (11), is provided in a head rest. It has a crosspiece (12), clipped (14) to the head support (5) and right and left deformable wings (15, 16). These are longer than the support wings (5, 6) of the head part (4), extending past distal edges (17) of the support wings. The deformable wings are spaced inwards from the support wings, with voids (18) defined between them. The deformable wings are divided into two in their forwards extent by a living hinge (19) into a front portion (20) and a rear portion (21). The living hinge is positioned just inside the distal edges of the shell wings. The injection moulded lining has its own foam materiel lining (22), the whole being covered with upholstery (23). The result of the arrangement is that if an occupant's head H impacts the lining in side impact of the vehicle equipped with the seat, the relevant lining wing will be pressed against the shell wing. This involves energy absorbing (maximum acceleration limiting) deformation of not only the foam material, but also of the lining wing and to a less extent of the shell wing. With the lining wing deformation (24), the front portion (20) of the lining wing pivots forwards about the shell edge (17), from a position swept back with respect to the shell wing to a position generally in line with the compressed inner portion of the lining.
Patent AU-2005238635-B2 (AU)
Title: Non-elispot assay
Inventor: STEN BRAESCH-ANDERSEN
IPC: G01N33/569
Filed: 2005-04-29
Granted: 2011-11-03
Abstract: A method of detecting the production of an analyte by cells in a sample, which method comprises: (i) providing an antibody capable of binding to said analyte and a first agent capable of enhancing detection of said analyte, wherein said antibody and said first agent are immobilised on the same support; (ii) contacting said antibody and said agent with a sample of cells; and (iii) detecting binding of said analyte to said antibody thereby detecting the production of an analyte by cells in a sample.
Patent AU-2005254945-B2 (AU)
Title: 2,4-Diaminoquinazolines for spinal muscular atrophy
Inventor: GURNEY MARK E
IPC: C07D239/95
Filed: 2005-06-06
Granted: 2012-11-08
Abstract: 2,4-Diaminoquinazolines of formulae I-IV and VI (I, II, III, IV and VI) are useful for treating spinal muscular atrophy (SMA).
Patent AU-2006210880-B2 (AU)
Title: AXMI-018, AXMI-020, and AXMI-021, a family of delta-endotoxin genes and methods for their use
Inventor: HARGISS TRACY
IPC: A01N63/50
Filed: 2006-01-31
Granted: 2012-09-20
Abstract: Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for a delta-endotoxin polypeptide are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated delta-endotoxin nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides for isolated nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequence shown in SEQ ID N0: 2, 4, or 6, or the nucleotide sequence set forth in SEQ ID NO: 1, 3, or 5, as well as variants and fragments thereof.
Patent AU-2006243552-B2 (AU)
Title: Device for changing bridges, side arms and browbars of rimless spectacles, and for changing bridges and side arms of metallic and plastic spectacle frames
Inventor: GUNTHER WIED
IPC: G02C5/14
Filed: 2006-05-02
Granted: 2011-07-14
Abstract: In exchangeable spectacle frames, in which the side arms and bridge are fastened to the lenses or central part of the spectacle frame by a support element, the support element is a rod-shaped, rail-shaped or plate-shaped metal part with a metallic threaded pin and an additional metallic positioning pin or threaded pin. The metallic or plastic end of the side arm on the side of the lens, or the connecting element between the support element and metallic or plastic side arm, is shaped with recesses which are adapted to the form of the support element, have the same length as the metallic part and engage the metallic part. The recesses in the side arm form at least two catches on the lateral, inner plastic interfaces which interact with the threaded pin and positioning pin. Alternatively, the side arms or bridges are made of an elastic material with a slit-shaped recess, in which recesses are located for form-fittingly receiving the pins of the support element and locking them after their insertion.
Patent AU-2006291990-B2 (AU)
Title: Methods and compositions for modulating tumor cell activity
Inventor: CANTIN CHRISTIANE
IPC: A61K38/17
Filed: 2006-09-13
Granted: 2012-05-31
Abstract: Antibodies which target clusterin, a protein involved in the epithelial-to-mesenchymal transition of carcinoma cells, are identified and characterized. The antibodies may be used to modulate tumour cell activity through binding to clusterin.
Patent AU-2006292147-B2 (AU)
Title: TDF-related compounds and analogs thereof
Inventor: SWORIN MICHAEL
IPC: G01N33/53
Filed: 2006-09-20
Granted: 2013-03-07
Abstract: The present invention relates generally to tissue differentiation factor (TDF) analogs. More specifically, the invention relates to structure-based methods and compositions useful in designing, identifying, and producing molecules, which act as functional modulators of TDF-like receptors. The invention further relates to methods of detecting, preventing , and treating TDF-associated disorders.
Patent AU-2006313123-B2 (AU)
Title: Nucleic acid base having perfluoroalkyl group and method for producing the same
Inventor: KYOKO YAMAMOTO
IPC: C07D473/34
Filed: 2006-11-06
Granted: 2012-01-12
Abstract: It is intended to provide a simple and efficient method for producing a nucleic acid base having a perfluoroalkyl group. In the presence of a sulfoxide, a peroxide and an iron compound, by reacting a halogenated perfluoroalkyl and a nucleic acid base (for example, a uracil, a cytosine, an adenine, a guanine, a hypoxanthine, a xanthine or the like), a perfluoroalkyl nucleic acid base useful as a pharmaceutical intermediate is economically produced.
Patent AU-2006323918-B2 (AU)
Title: Plug intended to be inserted into a duct on which a fluid flows and associated fluid prospecting well
Inventor: PIERRE-ARNAUD FOUCHER
IPC: E21B33/128
Filed: 2006-12-06
Granted: 2011-09-01
Abstract: This plug comprises a body (16) having a longitudinal axis (X-X’) and a radially expandable annular assembly (18). The annular assembly (18) has a peripheral surface (39) for pressing against a duct and a peripheral surface (57) for pressing against the body (16). The annular assembly (18) comprises, around the longitudinal axis (X-X’), a plurality of radial expansion blocks (40, 42). Each block (40, 42) has a first bearing surface (44), a second bearing surface (46) and two lateral surfaces (48A, 48B) positioned facing a respective lateral surface (48B, 48A) of at least one adjacent block (42, 40). The blocks (40, 42) can move relative to one another between a radially contracted configuration and a radially expanded inserted configuration in which each lateral surface (48A, 48B) of one block (40, 42) is in contact with the lateral surface (48B, 48A) of the adjacent block (42, 40).
Patent AU-2007229958-B2 (AU)
Title: Universal external control device for use by multiple conditional access users with varying access to functionality of an implantable medical device
Inventor: GINGGEN ALEC
IPC: A61F2/48
Filed: 2007-10-23
Granted: 2013-07-04
Abstract: Abstract A universal external control device for use by multiple conditional access users with varying access to functionality of an implantable medical device in wireless communication therewith. Circuitry associated with the external control 5 device is used to uniquely identify each of the conditional access users via an access device such as a key or card. Access to functionality of the implantable medical device is restricted by the universal external control device based on the conditional access user identified by the access device.
Patent AU-2007249141-B2 (AU)
Title: Animal Carcuss Cutter
Inventor: SEATON MARK HAMISH
IPC: A22C17/00
Filed: 2007-12-20
Granted: 2013-07-04
Abstract: - 21 An animal carcass cutter having first and second circular knives for cutting meat and soft tissue when the knives and the carcass are brought into contact, wherein the first Knife is maintained proximate to the second knife defining a cutting region therebetween for 5 receiving the carcass. The first and second knives are preferably configured to rotate such that they move in a direction substantially opposite to the first direction in the cutting region. A~-~--100 a a
Patent AU-2007252295-B2 (AU)
Title: Selective modulation of receptor signalling
Inventor: HII CHARLES S T
IPC: C12Q1/68
Filed: 2007-05-18
Granted: 2013-07-25
Abstract: The present invention relates to a method of selectively modulating a signalling pathway of interest controlled by a cell receptor involved in signalling through multiple signalling pathways The method includes exposing the receptor to an agent that modulates signalling by the receptor through the signalling pathway of interest and does not substantially modulate signalling through one or more other signalling pathways controlled by the receptor.
Patent AU-2007264043-B2 (AU)
Title: Extracts of Aphanizomenon Flos Aquae and nutritional, cosmetic and pharmaceutical compositions containing the same
Inventor: CANESTRARI FRANCO
IPC: A61K8/97
Filed: 2007-06-27
Granted: 2012-03-15
Abstract: The invention provides extracts of the microalga Aphanizomenon Flos Aquae Aquae Ralfs ex Born. & Flah. Var. flos aquae (AFA Klamath) and biologically active components thereof, in particular AFA-phycocyanins, determined as the complex c-phycopcyanin/phycoerythrocyanin (including the chromophore phycoviolobilin), AFA-phytochrome and mycosporine-like aminoacids (MAAs), nutritional, cosmetic and pharmaceutical compositions containing the same, for use in the prophylaxis or treatment of diseases, disturbances or conditions involving acute or chronic inflammation and oxidative degeneration of body cells or tissues or uncontrolled cell proliferation.
Patent AU-2007288793-B2 (AU)
Title: Salt of phenoxypyridine derivative or crystal thereof and process for producing the same
Inventor: MATSUSHIMA TOMOHIRO
IPC: A61P35/00
Filed: 2007-08-21
Granted: 2012-04-19
Abstract: It is intended to provide an acid addition salt of a compound represented by the formula (1) or (2) or a crystal thereof and a process for producing the same. Such a salt or crystal has an HGFR inhibitory action and excellent physical properties (solubility, safety, etc.), therefore, it is useful as an antitumor agent for various tumors, an angiogenic inhibitor or a cancer metastasis inhibitor.
Patent AU-2007289066-B2 (AU)
Title: Direct liquid-phase collection and processing of fullerenic materials
Inventor: RICHTER HENNING
IPC: B01D11/00
Filed: 2007-08-31
Granted: 2012-09-06
Abstract: An in-situ method and system of collecting, in a liquid, non-agglomerated fullerenic material from a gaseous suspension is provided. The method and system collects non- agglomerated fullerenic material by contacting a gaseous suspension comprising fullerenic material with a suspension liquid, so as to capture the fullerenic material in the suspension liquid; and collecting the liquid suspension as a suspension liquid containing the fullerenic material. This method and system may be particularly useful for collecting fullerenes or nanotubes and maintaining them in solution in non-agglomerated states.
Patent AU-2007346889-B2 (AU)
Title: Compressible photonic crystal
Inventor: ARSENAULT ANDRE
IPC: G02B1/04
Filed: 2007-02-16
Granted: 2014-05-15
Abstract: A compressible photonic crystal comprising a polymer with an ordered array of voids, the photonic crystal having a reflectance in a first wavelength range for light incident to its incident surface and its opposing incident surface; wherein compression against at least a portion of at least one of the surfaces shifts the reflectance to a second wavelength range in at least that portion of that surface. The crystal may be used in authentication devices of various types.
Patent AU-2007352608-B2 (AU)
Title: Novel pharmaceutical composition
Inventor: MULLER FRANCIS X
IPC: A61K9/00
Filed: 2007-08-01
Granted: 2011-12-08
Abstract: Disclosed are novel pharmaceutical compositions containing 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[ 1,1 '-biphenyl]-3-carboxylic acid bis-(monoethanolamine) (eltrombopag olamine) and processes for preparing the same.
Patent AU-2007354294-B2 (AU)
Title: Antimicrobial cementitious composition, method and article
Inventor: ONG IVAN W
IPC: C04B24/02
Filed: 2007-05-29
Granted: 2012-11-01
Abstract: An antimicrobial cementitious composition for imparting antimicrobial characteristics to cement comprises a cement-based compound and an imazalil agent; combinations of agents also may be employed.
Patent AU-2008205169-B2 (AU)
Title: Imidazole derivatives as kinesin spindle protein inhibitors (Eg-5)
Inventor: WANG WEIBO
IPC: A61K31/422
Filed: 2008-01-03
Granted: 2012-02-02
Abstract: The present invention relates to new substituted imidazole compounds have the following Formula (I) and to the pharmaceutically acceptable salts, esters, or prodrugs thereof, to compositions of the compounds together with pharmaceutically acceptable carriers, and to uses of the compounds: (I).
Patent AU-2008216993-B2 (AU)
Title: Gaming machine and method
Inventor: BRETT MEZEN
IPC: A63F13/10
Filed: 2008-09-12
Granted: 2012-01-12
Abstract: A gaming machine for providing a game in which a plurality of symbols are selected and displayed in an array of symbol positions on a display, each symbol position associated with one or more of a plurality of regions and each region of the 5 plurality of regions associated with a region specific award. The gaming machine comprises a user interface in communication with a game controller. If a winning combination of symbols occurs such that at least one of the symbols of the winning combination of symbols is displayed in a symbol position associated with a first region of said plurality of regions, the region specific award associated with the first region is 10 awarded. If the same winning combination of symbols occurs such that at least one of the symbols of the winning combination of symbols is displayed in a symbol position associated with a second region of said plurality of regions, the region specific award associated with the second region is awarded. 404A 404B 404C 404D 404E 406 4 - 402A 408 Figure 4A 400 404A 404B3 404C 404D 404E 406 Figure 4B 404A 4043 404C 404D 404E 406 410- A A/A4028 Figure 4C
Patent AU-2008240181-B2 (AU)
Title: Tuberculosis vaccine and method of using same
Inventor: LIGHTER JENNIFER
IPC: A61K39/00
Filed: 2008-04-11
Granted: 2014-01-09
Abstract: Provided is a pharmaceutical composition that includes one or more inactivated Mycobacterium spp., which are preferably inactivated using gamma irradiation, and which is than formulated for mucosal or pulmonary delivery to a subject. The pharmaceutical compositions are useful for preventing or treating mycobacterium-associated infections in a subject, including a human subject.
Patent AU-2008248330-B2 (AU)
Title: Breathing-gas delivery system with exhaust gas filter body and method of operating a breathing-gas delivery system
Inventor: FUHRMAN BRADLEY P
IPC: A61M16/00
Filed: 2008-05-08
Granted: 2014-07-10
Abstract: Breathing-gas delivery systems and methods are described. In one such system there is a movable partition, a housing and a filter body. The housing is disposed about the movable partition, and thereby provides a respirator side on a first side of the partition, and a patient side on a second side of the partition. The housing also has (a) a patient inspiration orifice on the patient side, which is adaptable to supply breathing-gas to a patient, and (b) a gas exhaust orifice on the patient side.
Patent AU-2008259907-B2 (AU)
Title: Nucleic acid functionalized nanoparticles for therapeutic applications
Inventor: GILJOHANN DAVID A
IPC: C12N15/87
Filed: 2008-05-30
Granted: 2014-12-04
Abstract: Materials and methods for modulating cellular uptake of functionalized nanoparticles are provided. Also provided are materials and methods for modulating the effectiveness of a therapeutic agent with a functionalized nanoparticle.
Patent AU-2008274161-B2 (AU)
Title: Novel esterases and their use
Inventor: HALONEN PASI
IPC: D06L4/40
Filed: 2008-07-08
Granted: 2014-07-24
Abstract: The present invention relates to polyesterases having cutinase and/or suberinase activity obtainable from
Patent AU-2008279685-B2 (AU)
Title: Dynamic media zones systems and methods
Inventor: BOCCON-GIBOD GILLES
IPC: H04N21/835
Filed: 2008-07-23
Granted: 2013-06-13
Abstract: Systems and methods are described for applying digital rights management techniques to manage zones in electronic content. In one embodiment, zones are defined in a piece of electronic content, and a license is associated with the electronic content that indicates how the zones are to be accessed or otherwise used. A digital rights management engine governs access to or other use of the zoned content in accordance with the license.
Patent AU-2008280831-B2 (AU)
Title: Apparatus and method for determining the award of a prize
Inventor: WRIGHT DEAN
IPC: A63F13/12
Filed: 2008-07-24
Granted: 2012-12-06
Abstract: Apparatus (1) is disclosed for determining the award of a prize. The apparatus includes memory (2) for storing prize data indicative of a prize value for the prize. An input device (4) is responsive to input signals from a respective plurality of gaming terminals (6) for providing an increment signal. An increment device (8) is responsive to the increment signal for incrementing an accumulating value. A comparator (15) is responsive to the prize data and the accumulating value for determining if the prize is to be awarded and, if not, generating a continue signal. A processor (15) is responsive to the continue signal for refreshing the prize data.
Patent AU-2008283116-B2 (AU)
Title: Combined brewing system
Inventor: WILLIAMS IAN STUART
IPC: C12C13/02
Filed: 2008-07-31
Granted: 2013-05-16
Abstract: The invention relates to a combined brewing system for home or small scale brewing of fermented alcoholic beverages, particularly beer, and to a method of making fermented alcoholic beverages. The brewing system comprises a single pressurizable vessel having means for naturally carbonating the beer to the desired level during fermentation, for collecting and substantially separating any sediment from within the vessel and removing it from the vessel while the vessel is under pressure, means for receiving compressed gas for dispense purposes and for maintaining natural carbonation levels, and a draft dispense draw off mechanism for drawing off the contents of the vessel at a desired pressure. The vessel has or is adapted to be coupled with a temperature control system to selectively control the temperature of the contents of the vessel during all stages of processing. Accordingly the vessel or system is capable of accommodating at least the brewing steps of fermentation, natural carbonation, maturation, and draw off so that, in use, the processing is less time consuming and labour intensive compared to other small and large scale brewing processes and the risk of contamination of the contents of the vessel by air and/or undesirable micro-organisms during the brewing process is minimized thereby producing an improved quality beverage.
Patent AU-2008290273-B2 (AU)
Title: Process
Inventor: LARSEN NIELS ERIK
IPC: C07K14/195
Filed: 2008-08-14
Granted: 2014-01-09
Abstract: The use of a lipid acyltransferase in the manufacture of UHT milk for improving the stability, particularly the long term stability, and/or improving the perceptible sensory difference and/or improving smell and/or taste and/or for reducing the cholesterol content and/or for eliminating or reducing creaming of the UHT milk for reducing the cholesterol content in the UHT milk. A method of producing UHT milk, wherein method comprises admixing a lipid acyltransferase and milk (including a step of processing the milk to make it a UHT milk). Preferably said lipid acyltranferase is a polypeptide having lipid acyltransferase activity which polypeptide is obtained by expression of the nucleotide sequence shown as SEQ ID No. 49 or a nucleotide sequence which as has 70% or more identity therewith; and/or is obtained by expression of a nucleic acid which hybridises under medium stringency conditions to a nucleic probe comprising the nucleotide sequence shown as SEQ ID No. 49; and/or is a polypeptide having lipid acyltranferase activity which polypeptide comprises the amino acid sequence shown as SEQ ID No. 68 or an amino acid sequence sequence which as has 70% or more identity therewith.
Patent AU-2008331500-B2 (AU)
Title: Intravesical compositions with valrubicin for the treatment of bladder cancer
Inventor: CHABER JOHN
IPC: A61P35/00
Filed: 2008-11-26
Granted: 2013-11-21
Abstract: Compositions and methods for the treatment of bladder cancer include intravesical dosage forms of a neoplastic agent and a permeation enhancer. The neoplastic agent may be valrubicin. Pharmaceutical compositions include intravesical dosage forms of a neoplastic agent complexed liposomes. Tight junction openers may be used for the effective delivery of the neoplastic agent.